• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Solesence Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    12/1/25 12:23:33 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SLSN alert in real time by email
    false 0000883107 0000883107 2025-11-21 2025-11-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 1, 2025 (November 21, 2025)

     

    SOLESENCE, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 0-22333 36-3687863
    (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

     

    1319 Marquette Drive

    Romeoville, Illinois 60446

    (Address of Principal Executive Offices) (Zip Code)

     

    (630) 771-6708

    (Registrant's telephone number, including area code)

     

    Not applicable

     (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule l 4a-12 under the Exchange Act ( 17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, $0.01 par value per share SLSN The NASDAQ Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

    Item 1.01 Entry into a Material Definitive Agreement.

     

    Effective November 22, 2025, Solesence, Inc. (the "Company") entered into a Consulting Agreement (the "Consulting Agreement") with Jess Jankowski. As previously disclosed, Mr. Jankowski, who formerly served as Chief Executive Officer and Chief Financial Officer of the Company, served as Board Advisor to the Company through his retirement on November 21, 2025. Pursuant to the Consulting Agreement, Mr. Jankowski will provide up to 80 hours of consulting services to the Company pertaining to management, financial record, SEC filings and related matters of the Company in exchange for a consulting fee of $177 per hour.

     

    The description of the terms and conditions of the Consulting Agreement does not purport to be complete and is qualified in its entirety by the full text of the Consulting Agreement, which is filed as an exhibit to this Current Report on Form 8-K.

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    As disclosed in Item 1.01 of this current report on Form 8-K, which is incorporated into this Item 5.02, effective November 21, 2025, Jess Jankowski retired and resigned from his position on the Board of Directors of the Company (the "Board"). Effective immediately upon Mr. Jankowski's retirement, the Board appointed Kevin Cureton, the Company's Chief Executive Officer and President, to serve as a Class III Director of the Board for the remainder of Mr. Jankowski's term. Consistent with Mr. Jankowski not serving on any committees of the Board, the Board does not anticipate appointing Mr. Cureton to any committees of the Board. The Board also formally recognized Mr. Jankowski's long and dedicated service to the Company and its shareholders, customers, and employees, and the Board expressed its appreciation to Mr. Jankowski for his many contributions to the Company.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
            
    10.1   Jess Jankowski Consulting Agreement, dated November 22, 2025.
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 1, 2025

     

      SOLESENCE, INC.
         
       
    By:  /s/ Laura Riffner
        Laura Riffner
        CFO

     

    Get the next $SLSN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SLSN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SLSN
    SEC Filings

    View All

    Solesence Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - SOLESENCE, INC. (0000883107) (Filer)

    12/2/25 7:11:43 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solesence Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - SOLESENCE, INC. (0000883107) (Filer)

    12/1/25 12:23:33 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solesence Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SOLESENCE, INC. (0000883107) (Filer)

    11/12/25 7:30:28 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    $SLSN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore R Janet bought $63,274 worth of shares (35,056 units at $1.80), increasing direct ownership by 2% to 2,084,198 units (SEC Form 4)

    4 - SOLESENCE, INC. (0000883107) (Issuer)

    12/11/25 11:50:36 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 3 filed by new insider Riffner Laura C

    3 - SOLESENCE, INC. (0000883107) (Issuer)

    10/6/25 10:07:15 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Chief Operating Officer Cureton Kevin exercised 43,500 shares at a strike of $0.42 and sold $166,051 worth of shares (43,500 units at $3.82) (SEC Form 4)

    4 - SOLESENCE, INC. (0000883107) (Issuer)

    6/6/25 7:00:04 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    $SLSN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore R Janet bought $63,274 worth of shares (35,056 units at $1.80), increasing direct ownership by 2% to 2,084,198 units (SEC Form 4)

    4 - SOLESENCE, INC. (0000883107) (Issuer)

    12/11/25 11:50:36 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Large owner Whitmore Bradford T bought $28,093,800 worth of shares (6,689,000 units at $4.20) and sold $28,093,800 worth of shares (6,689,000 units at $4.20) (SEC Form 4)

    4 - SOLESENCE, INC. (0000883107) (Issuer)

    6/2/25 4:01:15 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    $SLSN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Solésence Reports Third Quarter 2025 Financial Results

    Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and Accomplishments Continued strategic transformation to drive future innovation and growth with promotion of Kevin Cureton to President and Chief Executive Officer.Appointed Laura Riffner, a seasoned financial and operations expert, as Chief Financial Officer to lead accounting and finan

    11/11/25 7:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

    Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Company's continued innovation and operational excellence in its new phase of growth. Dvorzsak will lead a newly unified group that combines Solésence's research and development, product and component de

    11/10/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call

    ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2025 before the market opens on Tuesday, November 11, 2025, and host a conference call and webcast on the same date. Third Quarter 2025 Conference Call DetailsDate / Time: Tuesday, November 11, 2025 – 7:30 a.m. CDT, 8:30 a.m. EDT Speakers: Kevin Cureton, President & CEO, Laura Riffner, Chief Financial Officer, and Jess Jankowski, Board Advisor Webcast Link: https://edge.media-server.com/mmc/p/qur8mp24 Dial-In Link: https://registe

    10/30/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    $SLSN
    Leadership Updates

    Live Leadership Updates

    View All

    Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

    Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Company's continued innovation and operational excellence in its new phase of growth. Dvorzsak will lead a newly unified group that combines Solésence's research and development, product and component de

    11/10/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth

    ROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced strategic changes to its executive leadership. Kevin Cureton, a driving force behind the company's expansion and innovation, will assume the role of President and Chief Executive Officer. Laura Riffner has been appointed Chief Financial Officer, bringing decades of financial expertise in enhancing operational excellence and efficiency. Jess Jankowski, who has been at the helm of the company as Chief Executive Officer since 2009, will serve as Board Advisor until his retirement from the company

    9/3/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence to Join Russell 3000® and Russell 2000® Indexes

    ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it will be added as a member of the broad-market Russell 3000® and small-cap Russell 2000® Indexes, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or

    6/24/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    $SLSN
    Financials

    Live finance-specific insights

    View All

    Solésence Reports Third Quarter 2025 Financial Results

    Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and Accomplishments Continued strategic transformation to drive future innovation and growth with promotion of Kevin Cureton to President and Chief Executive Officer.Appointed Laura Riffner, a seasoned financial and operations expert, as Chief Financial Officer to lead accounting and finan

    11/11/25 7:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call

    ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2025 before the market opens on Tuesday, November 11, 2025, and host a conference call and webcast on the same date. Third Quarter 2025 Conference Call DetailsDate / Time: Tuesday, November 11, 2025 – 7:30 a.m. CDT, 8:30 a.m. EDT Speakers: Kevin Cureton, President & CEO, Laura Riffner, Chief Financial Officer, and Jess Jankowski, Board Advisor Webcast Link: https://edge.media-server.com/mmc/p/qur8mp24 Dial-In Link: https://registe

    10/30/25 8:00:00 AM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary

    Solésence Reports Second Quarter 2025 Financial Results

    ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025.    Recent Highlights and Accomplishments Joined broad-market Russell 3000® and small-cap Russell 2000® IndexesAmended loan agreements to fuel growth initiatives "During our seasonally highest-performing quarter, we're pleased with the effectiveness of our commercial execution and the consistent, on-time delivery of products to our partners," said Jess Jankowski, President and Chief Executive Officer of Solésence. "Innovation

    7/31/25 4:01:00 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary